Known targets — ChEMBL curated mechanism
SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A
The experimentally established mechanism targets of Moricizine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 1/20 | 1.00 |
| ▸ | HTR1A | P08908 | 1/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 1/20 | 1.00 |
| ▸ | PDE4D | Q08499 | 1/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 7/20 | 0.98 |
| ▸ | MEN1 | O00255 | 3/20 | 0.98 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.98 |
| ▸ | GAA | P10253 | 2/20 | 0.98 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.98 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.98 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.82 |
| ▸ | NR1I3 | Q14994 | 4/20 | 0.73 |
| ▸ | MAPT | P10636 | 5/20 | 0.70 |
| ▸ | TP53 | P04637 | 2/20 | 0.70 |
| ▸ | HTT | P42858 | 2/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.69 |
| ▸ | USP2 | O75604 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Moricizine SCHEMBL16794 | 1.00 | CYP3A4 (1.00) | CYP3A4NR1I2HTR1ACHRM1PDE4D | |
| Moricizine SCHEMBL41358 | 0.99 | LMNA (1.00) | CYP3A4NR1I2HTR1ACHRM1PDE4D | |
| Moricizine SCHEMBL41359 | 0.99 | LMNA (1.00) | CYP3A4NR1I2HTR1ACHRM1PDE4D | |
| Moricizine SCHEMBL9447065 | 0.98 | LMNA (0.98) | CYP3A4NR1I2HTR1ACHRM1PDE4D | |
| Moricizine SCHEMBL1650461 | 0.98 | CYP3A4 (0.97) | CYP3A4NR1I2HTR1ACHRM1PDE4D | |
| SCHEMBL15913933 | 0.89 | CYP3A4 (0.80) | CYP3A4NR1I2HTR1ACHRM1PDE4D | |
| Moricizine SCHEMBL2430390 | 0.88 | CYP3A4 (0.78) | CYP3A4NR1I2HTR1ACHRM1PDE4D | |
| SCHEMBL19225040 | 0.85 | NR1I3 (1.00) | CYP3A4NR1I2HTR1ACHRM1PDE4D | |
| SCHEMBL9446980 | 0.84 | LMNA (0.72) | CYP3A4NR1I2HTR1ACHRM1PDE4D | |
| Moricizine SCHEMBL28086262 | 0.84 | CYP3A4 (0.70) | CYP3A4NR1I2HTR1ACHRM1PDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119144639-A | Application of heterologous expression Moricin peptide in enhancing insecticidal activity of pathogenic fungi | 中国科学院分子植物科学卓越创新中心 | 2024-12-17 | — | — | CN | claimed |
| EP-3863708-B1 | MIXED IONIC CONDUCTORS AND CORRESPONDING DEVICES, SYSTEMS AND METHODS OF MAKING | BATTELLE MEMORIAL INSTITUTE (US) | 2024-09-11 | — | — | EP | claimed |
| EP-4232013-A2 | OPIOID-FREE COMPOSITIONS FOR ANESTHESIOLOGICAL APPLICATIONS AND RELATED METHODS AND SYSTEMS | Vaporworks Nursing Anesthesia Inc. (US) | 2023-08-30 | — | — | EP | claimed |
| EP-2991588-B1 | PROSTHETIC TISSUE VALVES | CORMATRIX CARDIOVASCULAR INC (US) | 2022-10-12 | — | — | EP | claimed |
| US-20220218740-A1 | OPIOID-FREE COMPOSITIONS FOR ANESTHESIOLOGICAL APPLICATIONS AND RELATED METHODS AND SYSTEMS | VAPORWORKS NURSING ANESTHESIA INC. | 2022-07-14 | — | — | US | claimed |
| EP-3618813-B1 | IMPROVED EXTENDED RELEASE HIGHLY LOADED DRUG COMPOSITIONS | LUBRIZOL ADVANCED MAT INC (US) | 2022-07-06 | — | — | EP | claimed |
| WO-2022084980-A2 | OPIOID-FREE COMPOSITIONS FOR ANESTHESIOLOGICAL APPLICATIONS AND RELATED METHODS AND SYSTEMS | VAPORWORKS NURSING ANESTHESIA INC. (US) | 2022-04-28 | — | — | WO | claimed |
| WO-2025217305-A1 | DEVICES, KITS, AND METHODS FOR DELIVERING MEDICATION VIA THE LUNGS | INCARDA THERAPEUTICS, INC. (US) | 2025-10-16 | — | — | WO | disclosed |
| US-12244954-B2 | Semiconductor device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-03-04 | — | — | US | disclosed |
| EP-4444881-A2 | GATA4-TARGETED THERAPEUTICS FOR TREATMENT OF CARDIAC HYPERTROPHY | University of Rochester (US) | 2024-10-16 | — | — | EP | disclosed |
| EP-4430187-A2 | ANTISENSE OLIGONUCLEOTIDES FOR MODIFYING PROTEIN EXPRESSION | University of Rochester (US) | 2024-09-18 | — | — | EP | disclosed |
| EP-4232013-A2 | OPIOID-FREE COMPOSITIONS FOR ANESTHESIOLOGICAL APPLICATIONS AND RELATED METHODS AND SYSTEMS | Vaporworks Nursing Anesthesia Inc. (US) | 2023-08-30 | — | — | EP | disclosed |
| CN-116515846-A | Silkworm cell adhesion protein Pxt1 gene and application | 郑州轻工业大学 | 2023-08-01 | — | — | CN | disclosed |
| WO-2023086292-A2 | GATA4-TARGETED THERAPEUTICS FOR TREATMENT OF CARDIAC HYPERTROPHY | UNIVERSITY OF ROCHESTER (US) | 2023-05-19 | — | — | WO | disclosed |
| CN-115997851-A | Application of insect antibacterial peptide recombinant protein in preparation of immunopotentiator feed additive for aquaculture | 辽宁省海洋水产科学研究院 | 2023-04-25 | — | — | CN | disclosed |
| CN-115997851-A | Application of insect antibacterial peptide recombinant protein in preparation of immunopotentiator feed additive for aquaculture | 辽宁省海洋水产科学研究院 | 2023-04-25 | — | — | CN | disclosed |
| CN-110709068-B | Improved sustained release high load pharmaceutical compositions | 路博润先进材料公司 | 2022-11-08 | — | — | CN | disclosed |
| US-20220218740-A1 | OPIOID-FREE COMPOSITIONS FOR ANESTHESIOLOGICAL APPLICATIONS AND RELATED METHODS AND SYSTEMS | VAPORWORKS NURSING ANESTHESIA INC. | 2022-07-14 | — | — | US | disclosed |
| EP-3618813-B1 | IMPROVED EXTENDED RELEASE HIGHLY LOADED DRUG COMPOSITIONS | LUBRIZOL ADVANCED MAT INC (US) | 2022-07-06 | — | — | EP | disclosed |
| WO-2022084980-A2 | OPIOID-FREE COMPOSITIONS FOR ANESTHESIOLOGICAL APPLICATIONS AND RELATED METHODS AND SYSTEMS | VAPORWORKS NURSING ANESTHESIA INC. (US) | 2022-04-28 | — | — | WO | disclosed |